Novel approach with fractional ultrapulse CO(2) laser for the treatment of upper eyelid dermatochalasis and periorbital rejuvenation.

Lasers in medical science

PubMedID: 23307441

Balzani A, Chilgar RM, Nicoli M, Sapountzis S, Lazzeri D, Cervelli V, Nicoli F. Novel approach with fractional ultrapulse CO(2) laser for the treatment of upper eyelid dermatochalasis and periorbital rejuvenation. Lasers Med Sci. 2013;.
Fractional ultrapulse CO(2) laser resurfacing improves photodamage, wrinkles, and acne scarring by ablation of damaged tissue with subsequent regeneration and remodeling of collagen. In this study, the authors examined the efficacy and safety of fractional CO(2) laser and introduce a novel approach to the treatment of upper eyelid dermatochalasis. We treated 20 patients with low and moderate upper eyelid dermatochalasis. We did photographic analysis of results by measuring distance of upper eyelid fold and lateral eyebrow in vertical axis from a horizontal line joining medial and lateral canthi. All patients underwent UltraPulse CO(2) laser (Microxel MX 7000) resurfacing at upper eyelid, superior to eyebrow, and in periorbital area. Measurements were taken before and at 3 and 6 months after the laser treatment. We evaluated results at 3 and 6 months after laser treatment and found that the UltraPulse CO(2) laser induced elevation of eyelid crease and brow position (1.62?±?0.69 and 2.110?±?0.66 mm at 3 months; 1.63?±?0.68 and 2.300?±?0.67 mm at 6 months, respectively) as compared to before the treatment. Side effects were mild, patients reported minor crusting and oozing that resolved within 48 to 72 h, edema (1-2 days), and moderate postoperative erythema resolved within 4 days. These data illustrate the safety and efficacy of fractional ultrapulse CO(2) laser in the treatment of low and moderate upper eyelid dermatochalasis with added advantage of nonsurgical brow lift.